Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases

• 作者: Ankita Srivastava Niharika Chandra Sunil Kumar
• 来源期刊: 世界药理学杂志
• 学科: 医学
• 关键词: ULCERATIVE colitis Crohn’s DISEASE Inflammatory bowel DISEASE GUT MICROBIOTA LACTIC acid bacteria
• 年，卷（期）: 2019,（3）
• 页码范围: 26-40
• 页数: 15页
• 分类号: R

摘要

Inflammatory bowel disease (IBD) has been a worldwide health problem. It is characterized by severe intestinal inflammation due to immune responses against the gut microbes in genetically susceptible individuals. The understanding of gut microbiota for its composition and complex interaction in normal and diseased conditions has been assisted by the use of molecular, metagenomics and meta transcriptomics studies. The alteration of intestinal microbiota is the key determinant in the degree of inflammation caused and the prolonged course of disease. The relationship between luminal gut bacteria and innate immunity is also of prime significance. Such developments have further led to the search of specific (including bacteria and fungi) as a causative agent of IBD. Although detailed research has been done for the role of gut microbiota in IBD, molecular mechanisms and related gene expression are still not well understood in this disease, which hampers the generation of effective therapeutic agents for IBD. This paper assessed various factors contributing to IBD, genetic dysbiosis and pathogenic influence in the gut microbiota, interactions such as microbiome-host immune system interaction and microbe-microbe interactions involved in IBD, currently available IBD therapies, followed by a detailed review on bacterial infections that might be involved in IBD, globally and specifically in India.